Aclarion’s Nociscan Platform Earns Diamond Pinnacle Award; 97% Surgical Success
Aclarion’s Nociscan platform won a Diamond Pinnacle Award for AI Innovation alongside its 2025 HLTH Digital Health Award, validating its MR spectroscopy-based SaaS solution for chronic low back pain. The Nociscan cloud platform delivers 97% surgical success for treated painful discs in a 266 million-patient market.
1. Pinnacle Award for AI Innovation
Aclarion’s Nociscan solution received a Diamond Pinnacle Award in the Clinical Decision AI category, adding to its 2025 HLTH Digital Health Award. This dual recognition underscores the growing validation of its AI-driven approach to identifying discogenic low back pain.
2. Nociscan Technology and Performance
The MR spectroscopy-based SaaS platform analyzes chemical biomarkers in intervertebral discs using proprietary algorithms to classify painful versus non-painful discs. Clinical data shows a 97% surgical success rate when physicians treat all Nociscan-positive discs.
3. Market Potential and Deployment
Chronic low back pain affects an estimated 266 million people worldwide, representing a large cost burden. Delivered via a cloud-based analytics platform, Nociscan can be rapidly deployed across imaging centers and health systems without new hardware.